Pandemics result in healthcare system crises and disease progression on a global scale - patients with chronic illness stay away from healthcare during and after pandemics due to fear. Diabetics are one portion of chronically ill patients who will not receive the routine care that keeps them healthy because the care may not be available for months. This creates a backlog of sick patients, and a dramatic increase in diabetic foot wounds, related amputations and mortality. we need to start preparing for what comes next. The MIMOSA device solution is a connected care platform that enables the patient and physician to communicate remotely for assessment and triage of diabetic foot ulcers. There is no current product available within the Canadian market that provides the same standardized remote monitoring components within 1 personal medical device, hence the need for the MIMOSA device under the current market conditions. There are diabetic monitoring products available that measure, in isolation, data points such as temperature, oxygenation etc, but the MIMOSA device has the ability to measure all pertinent components of standardized global diabetic foot ulcer monitoring.
Something looks off?